Topic: Business

This page shows 211 to 220 of 492 total podcasts in this series.
<<Newer | 1- | 11- | 21- | 31- | 41- | 51- | 61- | 71- | 81- | 91- | 101- | 111- | 121- | 131- | 141- | 151- | 161- | 171- | 181- | 191- | 201- | 211- | 221- | 231- | 241- | 251- | 261- | 271- | 281- | 291- | 301- | 311- | 321- | 331- | 341- | 351- | 361- | 371- | 381- | 391- | 401- | 411- | 421- | 431- | 441- | 451- | 461- | 471- | 481- | 491- | Older>>

Tony Coles - One Drug Pharmaceutical Companies

Moira Gunn interviews Dr. Tony Coles, President and CEO of Onyx Pharmaceuticals, about the challenges to a company that depends on a single drug for business success.
      details...

JJ Bienaime - Orphan Diseases

Dr. Moira Gunn talks to JJ Bienaime, President & CEO of BioMarin Pharmaceuticals about the problem of orphan diseases, diseases not yet under research by pharmaceutical companies because of a lack of financial incentive to market new medications for treatment.
      details...

Matt Gardner - California Biotech Companies

Moira interviews Matt Gardner, President & CEO, BayBIO, the Northern California Life Sciences Organization, about the organization's the new free online Impact 2009 Report about all the biotech companies in California and everything they are working on.
      details...

Peter Diedrich - Mobivox CRM

Voice is the most natural, comfortable form of communication, but most customer interaction is done through text. In this presentation from the 2009 Emerging Communications Conference, Peter Diedrich of Mobivox describes their new voice CRM platform that improves customer satisfaction and retention by including sales messages into typical customer interactions.
      details...

Social Networks and Financial Markets

Alexander Saint-Amand and Thomas A. Desmond describe how their firms use social networking techniques to meet the unique challenges of investment research and online trading. Saint-Amand explores how Gerson Lehrman Group qualifies & engages a global network of experts. Desmond details how TradeKing uses community features and user-generated content to change trading from a solitary experience to a social one.
      details...

Alan Quayle - The Business Case for Opening the Network

In this eComm talk, Alan Quayle talks about the pressures driving operators to open their network and how, whilst not groundbreaking, there is a justifiable business case. His presentation highlights some of the services operators can enable, and make profitable, through opening their network, whilst also highlighting some of the critical issues they face in doing so.
      details...

Jeremy Toeman - Protecting Your Digital Assets

What happens to your online assets when you die? How can you make sure that your family can gain access to your digital identity? Jeremy Toeman, founder and CEO of Legacy Locker, talks about how the company has developed a way to protect your online assets. He discusses the background of the service and the information Legacy Locker is meant to protect, as well as examples of the kind of options users have, as well as the security issues included.
      details...

Mark Madsen - Using Open Source BI in the Real World

As Business Intelligence becomes more and more popular as a way for companies to achieve an advantage, some companies ahead of the curve are adopting open source BI software. Analysts have not been positive in their predictions of open source use, but they may be mistaken. Mark Madsen describes the results of his study showing who is using open source BI software, why they're using it, and what the benefits are. His results indicate that while open source BI is not widely accepted yet, its users are just ahead of the curve.
      details...

Jamie Heywood - Patients Like Me

At PatientsLikeMe.com, people share data about their illnesses, the drugs they're taking, and the effects (and side effects) of their treatments. In this conversation, co-founder Jamie Heywood tells host Jon Udell that selling this data to drug companies is more than a good business. It aims to put patients into more direct contact with those companies, and help ensure that drug discovery and development meets their needs.
      details...

Sure, Data, Data Everywhere, But Is Any of It Any Good?

In the current web-based data explosion, buyers and sellers of financial data are struggling to stay relevant and ahead of the competition. What data matters any more? What doesn't? How do you know? Where do you look? Keith Ackerman and Eric Christiansen answer these questions during this talk from the O'Reilly Money:Tech Conference.
      details...
This page shows 211 to 220 of 492 total podcasts in this series.
<<Newer | 1- | 11- | 21- | 31- | 41- | 51- | 61- | 71- | 81- | 91- | 101- | 111- | 121- | 131- | 141- | 151- | 161- | 171- | 181- | 191- | 201- | 211- | 221- | 231- | 241- | 251- | 261- | 271- | 281- | 291- | 301- | 311- | 321- | 331- | 341- | 351- | 361- | 371- | 381- | 391- | 401- | 411- | 421- | 431- | 441- | 451- | 461- | 471- | 481- | 491- | Older>>